课题基金 / 基金详情

Training Program in Cardiometabolic Diseases

Training Program in Cardiometabolic Diseases
心脏代谢疾病培训计划
批准号:
10654558
负责人:
Glenn I Fishman
金额:
$56.44万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
未结题
起止时间:
2009-09-01 至 2025-06-30

项目摘要

项目成果

Glenn I Fishman的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 这是第二个竞争性的更新申请露丝L。Kirschstein Institutional National Research 服务奖(T32),最初成立于2009年,提供密切指导,多学科 博士后研究培训非常有前途的医生,科学家和博士,并准备他们的职业生涯 作为独立的心血管研究者。自成立以来,我们共招收了18名学员, 包括两个代表性不足的少数民族。我们项目的几乎所有毕业生都做出了重大贡献 心血管文献和相当大的比例已获得全职学术或工业 从事生物医学调查的职位。该计划的四名毕业生已被招募到 我们的心脏病学部门的教师作为全职医生研究者,所有人都成功地竞争了 独立的NIH或AHA资助。此次竞争续签申请有两大变化。第一、 这反映了纽约大学医学院越来越多的教职员工调查心血管并发症, 糖尿病和代谢紊乱,以及我们心脏病科和 内分泌学,在这次更新中,我们将T32重新命名为心脏代谢疾病培训计划 并任命内分泌科主任伊拉戈德堡博士担任联合项目主任(PD)。第二、 作为实施ABIM研究途径和临床研究者的预期结果 进入我们的内科住院医师计划的途径,我们有一个高度有才华的医学博士和 MD/PhD研究员寻求密集的博士后研究培训计划作为他们目标的下一步, 开展独立的研究事业。因此,我们要求扩大T32训练 每年增加6个职位。与过去一样,培训计划是建立在高度 完成和经验丰富的NIH资助的小学教员。课程包括严格的 教学法,个性化的指导计划,和密集的研究经验。培训计划开始 具有基础广泛的教育课程,为所有受训者提供基本知识基础, 强调研究工具和生物医学研究与疾病的重要表现之间的接口, 心血管疾病然后,受训人员将学习更专业的课程,并开始进行实质性的 在主要导师的指导下,在以下几个领域之一进行基于实验室的或临床研究项目 机构优势:心肌/离子通道生物学和疾病;血管生物学和疾病;代谢 心血管疾病的病因和临床研究。鉴于我们的记录,我们相信, 对该计划的持续支持将产生一个稳定的高素质和积极性的调查人员的管道 他们致力于在美国和其他地方改善心血管/心脏代谢健康。
英文摘要
PROJECT ABSTRACT This is the second competing renewal application for a Ruth L. Kirschstein Institutional National Research Service Award (T32), which was originally established in 2009 to provide closely mentored, multidisciplinary postdoctoral research training to highly promising physician-scientists and PhDs and prepare them for careers as independent cardiovascular investigators. Since its inception, we have enrolled a total of eighteen trainees, including two under-represented minorities. Almost all graduates of our program have contributed significantly to the cardiovascular literature and a substantial proportion have obtained full-time academic or industry positions engaged in biomedical investigation. Four graduates of the program have been recruited to the faculty of our Division of Cardiology as full-time physician-investigators and all have competed successfully for independent NIH or AHA funding. There are two major changes in this competing renewal application. First, reflecting the growing cadre of faculty at NYU School of Medicine investigating cardiovascular complications of diabetes and metabolic disorders and the tight integration of research in our Divisions of Cardiology and Endocrinology, in this renewal we have renamed this T32 the Training Program in Cardiometabolic Diseases and have named Dr. Ira Goldberg, Director of Endocrinology to the role of co-Program Director (PD). Second, as an anticipated consequence of implementing the ABIM Research Pathway and Clinical Investigator Pathway into our Internal Medicine residency program, we have a growing pipeline of highly talented MD and MD/PhD fellows seeking intensive postdoctoral research training program as the next step in their goal of launching independent research careers. Therefore, we are requesting an expansion of this T32 training program to six positions each year. As in the past, the training program is built upon a foundation of highly accomplished and experienced NIH-funded primary faculty members. The curriculum includes rigorous didactics, a personalized mentoring plan, and an intensive research experience. The training program begins with a broad-based educational curriculum that provides all trainees with a fundamental knowledge-base that stresses research tools and the interface between biomedical research and important manifestations of cardiovascular disease. Trainees will then pursue more specialized coursework and embark upon a substantial laboratory-based or clinical research project under the guidance of a Primary Mentor in one of several areas of institutional strength: Myocardial/Ion Channel Biology and Disease; Vascular Biology and Disease; Metabolic Causes of Cardiovascular Disease, and Clinical Research. Given our track-record, we are confident that continued support for this program will produce a steady pipeline of highly talented and motivated investigators who are committed to enhancing cardiovascular/cardiometabolic health in the United States and elsewhere.
期刊论文(148)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fcvm.2022.842556
发表时间: 2022
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: []
通讯作者:
DOI: 10.1093/cvr/cvac012
发表时间: 2023-03-17
期刊: Cardiovascular research
影响因子: 10.8
作者: []
通讯作者:
Murine cardiac vector-flow imaging with high-frequency 2D row-column CMUT arrays
Transcriptional regulation in the ventricular conduction system
Transcriptional regulation in the ventricular conduction system
FHFs and Cardiac Electrophysiology
海外基金